<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>Molecular Diversity Preservation International</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M576</article-id>
      <article-id pub-id-type="publisher-id">molbank-2008-M576</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>3-Dimethylaminomethylene-4-phenyl-1,3-dihydro-2H-1,5-benzodiazepin-2-one</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>El Rhazi</surname>
            <given-names>Abdelouahhab</given-names>
          </name>
        </contrib>
		<contrib contrib-type="author">
          <name>
            <surname>Baouid</surname>
            <given-names>Abdesselam</given-names>
          </name>
          <xref rid="c1-molbank-2008-M576" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Elhazazi</surname>
            <given-names>Said</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Boudina</surname>
            <given-names>Aicha</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Essaber</surname>
            <given-names>Mohamed</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2008-M576">Laboratoire de Chimie Mol&#xE9;culaire, Equipe de Chimie des H&#xE9;t&#xE9;rocycles et Valorisation des Extraits des Plantes, D&#xE9;partement de Chimie, Facult&#xE9; des Sciences-Semlalia, Universit&#xE9; Cadi Ayyad, B.P 2390, 40001 Marrakech, Maroc. E-mail: <email>elrhazi@yahoo.fr</email>, <email>baouid@yahoo.fr</email>, <email>s.elhazazi@ucam.ac.ma</email>, <email>aichaboudina@yahoo.fr</email>, <email>m.essaber@yahoo.fr</email></aff>
	   <author-notes>
        <corresp id="c1-molbank-2008-M576"><label>*</label>Author to whom correspondence should be addressed.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>04</day>
        <month>09</month>
        <year>2008</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>11</month>
        <year>2008</year>
      </pub-date>
      <volume>2008</volume>
      <issue>3</issue>
      <elocation-id>M576</elocation-id>
      <history>
        <date date-type="received">
          <day>23</day>
          <month>07</month>
          <year>2008</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>08</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2008 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland.</copyright-statement>
        <copyright-year>2008</copyright-year>
        <license>
          <p>This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).</p>
        </license>
      </permissions>
      <kwd-group>
        <kwd>1,5-Benzodiazepin-2-one</kwd>
		<kwd>dimethylformamide-dimethylacetal</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>In this paper, we describe a facile and efficient method to prepare compound <bold>2</bold>, which had been previously obtained by a Vilsmeier reaction using DMF/POCl<sub>3</sub> [<xref ref-type="bibr" rid="B1-molbank-2008-M576">1</xref>]. We found that employment of dimethylformamide-dimethylacetal (DMF-DMA) affords the title compound in better  purity  and higher yield.</p>
	<p><disp-formula>
<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2008-M576-i001.tif"/>
</disp-formula></p>
      <p>A mixture of 0.47 g (1.98 mmol) of 4-phenyl-1,3-dihydro-2H-1,5-benzodiazepin-2-one <bold>1</bold> [<xref ref-type="bibr" rid="B2-molbank-2008-M576">2</xref>,<xref ref-type="bibr" rid="B3-molbank-2008-M576">3</xref>] in 4.5 ml of dimethylformamide-dimethylacetal (DMF-DMA) was stirred at 100 &#xB0;C for 4 hours and then cooled to room temperature. Filtration and washing with a little cold diethyl ether gave 0.46 g (75%) of 3-dimethylaminomethylene-4-phenyl-1,3-dihydro-2H-1,5-benzodiazepin-2-one <bold>2</bold>. The product obtained was recrystallized from diethyl ether.</p>
      <p>Melting point: 224-225 &#xB0;C (Diethyl ether).</p> 
	  <p>MS (m/z, %): 292 ([M+H]<sup>+</sup>, 100%).</p>
      <p><sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz), &#x3B4;(ppm): 2.55 (s, 6H, (C<underline>H</underline><sub>3</sub>)<sub>2</sub>N), 2.80 (s, 1H, N<underline>H</underline>), 7.40 (s, 1H, C=C<underline>H</underline>-N(CH<sub>3</sub>)<sub>2</sub>), 6.80-7.90 (m, 9H, <underline>H</underline>-Ar).</p>
      <p><sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz), &#x3B4;(ppm): 43.50 (N(<underline>C</underline>H<sub>3</sub>)<sub>2</sub>), 98.02 (<underline>C</underline>-3), 121.47, 124.59, 127.34, 128.13, 128.67, 128.89, 130.65, 131.78, 141.86 (<underline>C</underline>-Ar), 151.18 (C=<underline>C</underline>H-N(CH<sub>3</sub>)<sub>2</sub>), 167.40 (<underline>C</underline>-4), 178.57 (<underline>C</underline>=O).</p> 
  </body>
  <back>
     <app-group>
    <app id="app1-molbank-2008-M576">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2008-M576-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2008-M576-s001-mod.mol">
   <label>Supplementary File 1</label>
</supplementary-material>
        <supplementary-material id="molbank-2008-M576-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2008-M576-s001.mol">
   <label>Supplementary File 2</label>
</supplementary-material>
    </app>
	</app-group>
	<ref-list>
      <title>References</title>
      <ref id="B1-molbank-2008-M576">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Solomko</surname>
              <given-names>Z.F.</given-names>
            </name>
            <name>
              <surname>Proshkina</surname>
              <given-names>V.N.</given-names>
            </name>
            <name>
              <surname>Bozhanova</surname>
              <given-names>N.Ya.</given-names>
            </name>
            <name>
              <surname>Loban</surname>
              <given-names>S.V.</given-names>
            </name>
            <name>
              <surname>Babichenko</surname>
              <given-names>L.N.</given-names>
            </name>
          </person-group>
          <article-title>Vilsmeier reaction with 4-phenyl-2,3-dihydro-1H-1,5-benzodiazepin-2-one</article-title>
          <source>Khim. Geterosikl. Soedin.</source>
          <year>1984</year>
          <fpage>223</fpage>
          <pub-id pub-id-type="doi">10.1007/BF00506289</pub-id>
        </citation>
      </ref>
      <ref id="B2-molbank-2008-M576">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ried</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Stahlhofen</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>&#xDC;ber heterocyclische siebenringsysteme, vii der reaktionsverlauf zwischen o-phenylendiamin und alkyliden-brenztraubens&#xE4;uren</article-title>
          <source>Chem. Ber.</source>
          <year>1957</year>
          <volume>90</volume>
          <fpage>828</fpage>
          <pub-id pub-id-type="doi">10.1002/cber.19570900530</pub-id>
        </citation>
      </ref>
      <ref id="B3-molbank-2008-M576">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nardi</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Tajana</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Rossi</surname>
              <given-names>S. J.</given-names>
            </name>
          </person-group>
          <article-title>Heterocyclic compounds from 3,3-dimercapto-1-aryl-2-propen-1-ones. Note 1. 4-aryl-1,3-dihydro-2H-1,5-benzodiazepine-2-thiones</article-title>
          <source>Heterocyc. Chem.</source>
          <year>1973</year>
          <volume>10</volume>
          <fpage>815</fpage>
          <pub-id pub-id-type="doi">10.1002/jhet.5570100524</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
